Stanford University Researchers Set To Begin Human Gene Editing Trials in 2018
Stanford University researchers plan to test new gene therapy technology, called CRISPR-Cas9, in human trials in 2018 at the university's first-ever cell manufacturing plant slated for completion in the spring. The research -- which experts say could be used to cure genetic diseases, such as sickle cell anemia and muscular dystrophy -- is currently being tested in cell-based and animal clinical trials.
- "Stanford Bringing Gene Editing to Patients With Deadly Diseases" (Krieger, San Jose Mercury News, 1/1).